TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 135 filers reported holding TG THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,885,000 | -48.1% | 257,110 | -9.1% | 0.00% | -57.1% |
| Q3 2021 | $9,412,000 | -14.6% | 282,818 | -0.5% | 0.01% | -12.5% |
| Q2 2021 | $11,024,000 | -22.2% | 284,202 | -3.3% | 0.01% | -27.3% |
| Q1 2021 | $14,169,000 | -1.0% | 293,968 | +6.9% | 0.01% | 0.0% |
| Q4 2020 | $14,309,000 | +111.0% | 275,063 | +8.5% | 0.01% | +83.3% |
| Q3 2020 | $6,782,000 | +61.4% | 253,453 | +17.5% | 0.01% | +50.0% |
| Q2 2020 | $4,203,000 | +122.3% | 215,780 | +12.3% | 0.00% | +100.0% |
| Q1 2020 | $1,891,000 | -5.3% | 192,201 | +6.9% | 0.00% | 0.0% |
| Q4 2019 | $1,996,000 | +226.7% | 179,801 | +65.3% | 0.00% | +100.0% |
| Q3 2019 | $611,000 | -20.2% | 108,800 | +22.9% | 0.00% | 0.0% |
| Q2 2019 | $766,000 | +12.2% | 88,500 | +4.1% | 0.00% | 0.0% |
| Q1 2019 | $683,000 | +72.5% | 85,000 | -11.9% | 0.00% | 0.0% |
| Q4 2018 | $396,000 | -26.7% | 96,506 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $540,000 | -55.7% | 96,506 | +4.2% | 0.00% | -50.0% |
| Q2 2018 | $1,218,000 | -19.4% | 92,600 | -13.0% | 0.00% | 0.0% |
| Q1 2018 | $1,511,000 | +73.3% | 106,400 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $872,000 | -30.8% | 106,400 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $1,261,000 | +18.0% | 106,400 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,069,000 | -13.8% | 106,400 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,240,000 | +140.3% | 106,400 | -4.1% | 0.00% | +100.0% |
| Q4 2016 | $516,000 | -42.9% | 111,000 | -4.9% | 0.00% | 0.0% |
| Q3 2016 | $903,000 | +19.4% | 116,700 | -6.5% | 0.00% | 0.0% |
| Q2 2016 | $756,000 | -31.1% | 124,800 | -3.0% | 0.00% | -50.0% |
| Q1 2016 | $1,097,000 | -32.6% | 128,700 | -5.7% | 0.00% | -33.3% |
| Q4 2015 | $1,628,000 | -12.8% | 136,500 | -26.3% | 0.00% | 0.0% |
| Q3 2015 | $1,867,000 | -39.2% | 185,200 | 0.0% | 0.00% | -40.0% |
| Q2 2015 | $3,072,000 | +31.1% | 185,200 | +23.6% | 0.01% | +66.7% |
| Q1 2015 | $2,343,000 | 0.0% | 149,800 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,343,000 | +184.0% | 149,800 | +93.8% | 0.00% | +200.0% |
| Q3 2014 | $825,000 | +13.6% | 77,300 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $726,000 | +212.9% | 77,300 | +107.8% | 0.00% | – |
| Q1 2014 | $232,000 | +62.2% | 37,200 | 0.0% | 0.00% | – |
| Q4 2013 | $143,000 | -24.3% | 37,200 | 0.0% | 0.00% | – |
| Q3 2013 | $189,000 | – | 37,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
| Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
| SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
| Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
| Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
| Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
| Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
| COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |